2200 Northern Boulevard
181 articles with Pall Corporation
Pall Corporation and ARTeSYN Biosolutions Collaboration Agreement Expanded to Accelerate Single-Use Technology Industrialization
Pall Corporation, a global leader in filtration, separation and purification, announced the next step in the collaboration agreement with ARTeSYN® Biosolutions, a leading innovator in single-use components and fluid management technologies.
University College London in Strategic Alliance with Pall Biotech to Open Fit-for-Purpose Biotech Centre of Excellence for Research, Development and Training
Pall Corporatio has progressed a strategic partnership with the University College London (UCL) Biochemical Engineering department with the creation of the UCL-Pall Biotech Centre of Excellence (CoE) for research and training.
Pall Corporation and G-CON Manufacturing Collaborate to Deliver Custom Scalable Turnkey PODs® for Flexible Continuous Bioprocess and Viral Vector Facility Solutions
G-CON Manufacturing and Pall Corporation are collaborating to bring turnkey continuous bioprocess or viral vector production facility solutions to the industry.
In the news release, Pall Corporation and Aetos Biologics Partner to Deliver Integrated, Off-the-Shelf Biosimilar Manufacturing Solutions, issued 12-Sep-2018 by Pall Corporation over PR Newswire, we are advised by a representative of the company that the "About Celltheon Corporation" information was included in error; and a new paragraph for "About Aetos Biologics" has been added.
Pall Corporation and Celltheon Form Strategic Partnership for Biotherapeutics Development and Manufacturing with CELLTHEON SMART™ Expression Platform
Pall Corporation has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company.
Pall Corporation and BioSciencesCorp Launch Strategic Partnership to Support Industry Drive Towards Integrated End-to-End Bioprocessing
Together they will deliver cost-effective manufacturing strategies, and efficient upstream and downstream process equipment and facility design solutions for manufacturers.
Pall Corporation and KANEKA Corporation Expand Exclusive Distribution Agreement to Feature New KANEKA KanCapA™ 3G Protein A Chromatography Sorbents
Pall Corporation is pleased to announce the extension of a consumables distribution agreement with KANEKA Corporation.
Newly Named Pall Biotech Business Unit Focuses on Flexible, Scalable End-to-End Drug Manufacturing Models for All Development Processes
The Pall Biotech business unit has been named to reflect an important strategic direction for the company.
New Stax mAx Clarification Platform From Pall Life Sciences Delivers Robust, Accelerated Performance Across Multiple mAb Processes
The single-use harvesting platform features a 4-layer concept, and has been optimized to maintain performance as cell density and viability change to minimize the impact of process variability between batches.
New Cadence Inline Diafiltration Modules Debuted at Pall Life Sciences Leadership Forum at Westborough, MA Center of Excellence
The modules will be exclusively showcased this week during the next installation of Pall's Leadership Forum series hosted in the Westborough, MA Center of Excellence.
The 3-year project aims to lower the cost of manufacturing mAbs significantly - to $5/g.
Pall Corporation Leaps Forward With Patient Care Focus Following FDA 510(K) Clearance For QPoint Water Filter Capsules
Pall Corporation And Roosterbio Announce Collaboration Agreement To Market Mesenchymal Stem/Stromal Cells And Bioreactor Expansion Systems
Orgenesis And Pall Corporation Receive $800,000 Grant From BIRD Foundation For Diabetes Research And Development